Annovis Bio Submits an International Patent Application to Cover the Treatment of Neurological Injuries Caused by Infections
Annovis Bio’s Current Intellectual Property Portfolio Covers the Use of Buntanetap, the Company’s Lead Compound, to Treat Neurodegenerative Diseases
With this Recent Filing, the Company Seeks Protection for Buntanetap to Treat Infection-Dependent Neurological Injuries